Merck stock price target lowered to $95 by Bernstein SocGen
Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...
Merck (MRK) Downgraded by TD Cowen Over Keytruda, Gardasil Concerns
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
Hosted on MSN18h
Merck Stock Heads For 5th Day Of Losses As TD Cowen Downgrades On Gardasil Woes, But Retail Holds Strong
Shares of Merck & Co. Inc. fell more than 0.5% on Monday afternoon, tracking their fifth consecutive decline in the worst ...
https//insights.som.yale.edu18h
What Investors Are Missing about Pfizer and Merck
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
HPV 'cures' are popping up online, but here's the truth about the STI and its vaccine
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...